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BACKGROUND: Current vaccines against HPVs are constituted of L1 protein self-
assembled into virus-like particles (VLPs) and they have been shown to protect
against natural HPV16 and HPV18 infections and associated lesions. In addition,
limited cross-protection has been observed against closely related types.
Immunization with L2 protein in animal models has been shown to provide cross-
protection against distant papillomavirus types, suggesting that the L2 protein
contains cross-neutralizing epitopes. However, vaccination with L2 protein or L2
peptides does not induce high titers of anti-L2 antibodies. In order to develop a
vaccine with the potential to protect against other high-risk HPV types, we have
produced HPV58 pseudovirions encoding the HPV31 L2 protein and compared
their capacity to induce cross-neutralizing antibodies with that of HPV L1 and HPV
L1/L2 VLPs.
METHODS: The titers of neutralizing antibodies against HPV16, HPV18, HPV31
and HPV58 induced in Balb/c mice were compared after immunization with L2-
containing vaccines.
RESULTS: Low titers of cross-neutralizing antibodies were detected in mice when
immunized with L1/L2 VLPs, and the highest levels of cross-neutralizing antibodies
were observed in mice immunized with HPV 58 L1/L2 pseudovirions encoding the
HPV 31 L2 protein.
CONCLUSIONS: The results obtained indicate that high levels of cross-
neutralizing antibodies are only observed after immunization with pseudovirions
encoding the L2 protein. HPV pseudovirions thus represent a possible new strategy
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